Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling PathwayInho Kim, Hae‐Young Lee|Korean Circulation Journal|2019Cited by 17